Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Free Cash Flow: 2020-2024

Historic Free Cash Flow for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to -$130.2 million.

  • Prime Medicine's Free Cash Flow fell 29.78% to -$35.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$115.1 million, marking a year-over-year increase of 39.52%. This contributed to the annual value of -$130.2 million for FY2024, which is 25.25% up from last year.
  • Prime Medicine's Free Cash Flow amounted to -$130.2 million in FY2024, which was up 25.25% from -$174.1 million recorded in FY2023.
  • Prime Medicine's Free Cash Flow's 5-year high stood at -$6.2 million during FY2020, with a 5-year trough of -$174.1 million in FY2023.
  • Its 3-year average for Free Cash Flow is -$150.7 million, with a median of -$147.9 million in 2022.
  • As far as peak fluctuations go, Prime Medicine's Free Cash Flow slumped by 518.34% in 2021, and later increased by 25.25% in 2024.
  • Yearly analysis of 5 years shows Prime Medicine's Free Cash Flow stood at -$6.2 million in 2020, then crashed by 518.34% to -$38.2 million in 2021, then crashed by 286.91% to -$147.9 million in 2022, then decreased by 17.72% to -$174.1 million in 2023, then rose by 25.25% to -$130.2 million in 2024.